Leukemia Drug for Parkinson’s: A Second Look

Leukemia Drug for Parkinson’s: A Second Look
The chronic myeloid leukemia drug nilotinib (Tasigna) did not produce biological or clinically meaningful effects that would benefit people with Parkinson's disease, the NILO-PD trial suggested. Over ... read more
Source: Bing NewsPublished on 2020-05-22